Merit Medical Systems (MMSI) Raw Materials (2015 - 2026)

Merit Medical Systems (MMSI) has 11 years of Raw Materials data on file, last reported at $114.6 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials fell 3.26% year-over-year to $114.6 million; the trailing twelve-month figure through Mar 2026 stood at $114.6 million (down 3.26% YoY), and the FY2025 full-year result was $110.7 million, changed 0.17% from the prior year.
• Raw Materials grew to $114.6 million in Q1 2026, from $110.7 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $119.6 million in Q4 2023 to a low of $68.4 million in Q1 2022.
• A 5-year average of $105.0 million and a median of $113.2 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials soared 52.23% in 2023 and declined 7.57% in 2024, its largest moves.
• Tracing MMSI's Raw Materials over 5 years: stood at $89.4 million in 2022, then soared by 33.72% to $119.6 million in 2023, then slipped by 7.57% to $110.5 million in 2024, then advanced by 0.17% to $110.7 million in 2025, then increased by 3.48% to $114.6 million in 2026.
• Business Quant data shows MMSI's Raw Materials at $114.6 million in Q1 2026, $110.7 million in Q4 2025, and $113.5 million in Q3 2025.